P.M. BRIEFING : Du Pont to Sell Virology Unit
- Share via
WILMINGTON, Del. — Du Pont Co. said today it will sell its virology blood-screening business to Johnson & Johnson and Chiron Corp. for undisclosed terms.
Du Pont, the nation’s No. 1 chemical company, said, “The sale is the first step in a strategy calling for increased spending in (our) core diagnostics business while divesting some non-strategic diagnostic product lines developed or acquired in recent years.”
The blood-screening business to be sold includes certain kits that detect the presence of acquired immune deficiency syndrome and other diseases in donated blood.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
